INFLUENZA A VIRUS A/Georgia/12/2022 CVR-167 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Victoria/800/2024 CVR-289 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Singapore/WUH4618/2021 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED) 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL Injection 0.5 mL (Flucelvax)
Core product details for sourcing, verification, and indexing.
| NDC 11 | 70461-0655-03 |
|---|---|
| Product NDC | 70461-0655 |
| Generic Drug Name | INFLUENZA A VIRUS A/Georgia/12/2022 CVR-167 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Victoria/800/2024 CVR-289 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Singapore/WUH4618/2021 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED) |
| Brand Name | Flucelvax |
| Manufacturer | Seqirus Inc. |
| Strength | 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL |
| Dosage Form | Injection |
| Drug Type | Intramuscular |
| Package Quantity | 10 Syringe, Glass |
| Package Description | 10 SYRINGE, GLASS in 1 CARTON (70461-655-03) / .5 mL in 1 SYRINGE, GLASS (70461-655-04) |
| Active Ingredients | Influenza A Virus A/Georgia/12/2022 Cvr-167 (H1N1) Antigen (Mdck Cell Derived, Propiolactone Inactivated); Influenza A Virus A/Victoria/800/2024 Cvr-289 (H3N2) Antigen (Mdck Cell Derived, Propiolactone Inactivated); Influenza B Virus B/Singapore/Wuh4618/2021 Antigen (Mdck Cell Derived, Propiolactone Inactivated) |
| Marketing Category | BLA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
Core NDC snapshot
INFLUENZA A VIRUS A/Georgia/12/2022 CVR-167 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Victoria/800/2024 CVR-289 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Singapore/WUH4618/2021 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED) 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL Injection is tracked under NDC 70461-0655-03 and rolls up into product family 70461-0655. Use this page to confirm the exact presentation before moving into related family or manufacturer pathways.
- Package configuration: 10 Syringe, Glass.
- Manufacturer: Seqirus Inc..
- Dosage form: Injection.
- Family size: 1 active presentation.
Click a tag to refine the catalog view around this exact presentation.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
INFLUENZA A VIRUS A/Georgia/12/2022 CVR-167 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Victoria/800/2024 CVR-289 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Singapore/WUH4618/2021 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED) 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL Injection 0.5 mL (Flucelvax), NDC 70461-0655-03, is a Seqirus Inc. 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL injection presentation packaged as 10 Syringe, Glass.
NDC search formats
- Canonical NDC 11: 70461-0655-03.
- Digits-only NDC 11: 70461065503.
- Possible 10-digit display formats: 70461-655-03 (7046165503), 70461-0655-3 (7046106553).
Multiple 10-digit display-format aliases can map to the same stored 11-digit billing NDC, so these are shown as search aliases rather than a single asserted package format.
Helpful product links
- Search by brand name: Flucelvax.
- Exact NDC 11: 70461-0655-03.
- Product family NDC: 70461-0655.